ELUT
ELUTIA INC.
NASDAQ · Healthcare · Biotechnology · US
$0.76
−6.59%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 33.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- 0.58x
- PEG TTM
- —
- Price / book
- 2.14x
- Price / sales
- 2.77x
- Price / cash flow
- -0.76x
Enterprise value
- Enterprise value
- $24.5M
- EV / sales
- 2.02x
- EV / EBITDA
- -1.02x
- EV / EBIT
- -1.04x
- Market cap
- $33.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026